INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 1996

Oral magnesium showed no prophylactic benefit over placebo in migraine patients.

In an interim evaluation of 69 patients with 2 to 6 migraine attacks per month, 10 of 35 patients (28.6%) taking 10 mmol magnesium twice daily responded, compared to 10 of 34 (29.4%) taking placebo. Migraine days and attacks showed no difference between groups. Mild adverse events occurred in 45.7% of the magnesium group versus 23.5% with placebo, prompting trial discontinuation.

Study type
Multicenter, randomized, double-blind, placebo-controlled trial
Who was studied
69 adults aged 18-64 with migraine
What was measured
Reduction of at least 50% in migraine attack intensity or duration in hours

THE PAPER

Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study.

Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, Taneri Z, Soyka D, Göbel H, Fischer M. Cephalalgia, 1996.

PubMed 8902254 ↗DOI 10.1046/j.1468-2982.1996.1606436.x ↗

Brain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.